From Regurgitation to Restoration: 🔄 The TTVR Revolution Redefines Tricuspid Therapy

  A landmark JAMA study on transcatheter tricuspid valve replacement (TTVR) offers compelling real-world evidence 🫀   ✅ 98.4% procedural success ✅ Near-complete TR elimination (97.7% at 30 days) ✅ Significant improvement in symptoms & quality of life ⚠️ Trade-off: ~16% new pacemaker rate in device-naïve patients   In an elderly, high-risk cohort, TTVR delivers what surgery often cannot—restoration without incision, relief without delay.   A meaningful step forward in structural heart disease—where the right heart finally takes center stage ✨